Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HT-3951 for Upper Extremity Motor Function in Ischemic Stroke
NCT02530307Phase 2Terminated
- Sponsor
- Dart NeuroScience LLC
- Start
- Feb 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HT-3951 in ischemic stroke, sponsored by Dart NeuroScience LLC. Started Feb 2016; status: terminated.
02
Drugs
HT-3951
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02530307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02530307.